PIK3CA and cervical cancer: Enhanced proliferation and glucose metabolism was further confirmed in cervical cancer cells and xenograft models with mutant PIK3CA. These results indicate that PIK3CA E542K and E545K mutations play a vital role in promoting glycolysis and proliferation in vitro and in vivo.